PFE
Pfizer Inc.
NYSE · Healthcare · Drug Manufacturers - General · US
$28.45
−1.25%Jun 24, 2026, 15:30 UTC
Pfizer was dismissed as a defendant in a US states' antitrust lawsuit alleging generic drug price-fixing.
Jun 23, 2026, 00:00 UTC
Avalo Therapeutics appointed Ron Philip as a director, effective June 23, 2026.
Jun 17, 2026, 00:00 UTC
Rigel Pharmaceuticals completed the acquisition of exclusive global rights to develop, manufacture and commercialize VEPPANU (vepdegestrant) from Arvinas entities and Pfizer.
Jun 6, 2026, 13:06 UTC
Pfizer presented data on Saturday showing that a monthly dose of an experimental obesity drug acquired through its purchase of Metsera last year had a similar side-effect profile as Novo Nordisk's Wegovy.
Source:
← PreviousPage 3